Cellular Dynamics: Human Cells. Endless Possibilities from Discovery to Regenerative Medicine.
CDI Notebook
TrendingArticlesCDI in the NewsUpcoming EventsApplications
CDI Notebook
Welcome to CDI Notebook
Trending: iForum 2017

iForum℠ 2017: Dates & Sites Released! Plan now to join us at one or all of this year's iForum meetings:

Sep 14 - The Buck Institute, Novato, CA
Sep 21 - Harvard Medical School, Boston, MA
Sep 28 - Imperial College, London, UK

Bookmark the iForum website to keep abreast of each conference's details as they become available.


Article: Deconvoluting Kinase Inhibitor Induced Cardiotoxicity

Deconvoluting Kinase Inhibitor Induced Cardiotoxicity. Read how AstraZeneca researchers are using iCell Cardiomyocytes to elucidate kinase inhibitor-induced cardiotoxicity. Their findings provide a framework for a predictive functional cardiotoxicity model with clinical translatability.

Lamore SD, Ahlberg E, et al. (2017) Toxicol Sci.


CDI in the News
CDI in the News: World’s Largest hiPSC Bank: Made in California.

World’s Largest hiPSC Bank: Made in California. Learn the key role that CDI has played in the California Institute for Regenerative Medicine (CIRM) cell banking initiative to advance scientific discovery by making well-characterized, high-quality hiPSCs available to researchers.


Upcoming Events
Upcoming Event: ISSCR 2017

ISSCR (Jun 14 - 17 | Boston, MA). Make sure to check out our Parkinson's Disease Innovation Showcase (Jun 15, 11:30 am - 12:30 pm | Room 258C) and posters W-2019, F1151, F-1153, and F-2110.

Stop by booth 707 for a chance to win a Fujifilm Instax camera.


Upcoming Event: BIO 2017

BIO (Jun 19 - 22 | San Diego, CA). Mark your calendar to attend the session Getting the Human into the Dish: The Roads towards More Predictive Clinical Models (Jun 19, 2:30 - 3:45 pm | Room 6D).


Upcoming Event: TERMIS

TERMIS-EU (Jun 26 - 30 | Davos, Switzerland). Join us to hear the latest innovations in regenerative medicine research.


Upcoming Event: PBSS

PBSS (Jun 28 | San Francisco Bay, CA). Visit our booth at the minisymposium Immuno-Oncology: Advances in Translating from Bench to Clinic.


Application: Myotoxicity Evaluation Using High Content Analysis (HCA)

Myotoxicity Evaluation Using High Content Analysis (HCA). Review how Servier scientists implemented iCell Skeletal Myoblasts in experimental designs to assess muscular toxicity of 15 reference drugs. HCA confirms these biologically relevant cells may be used as a screening tool for candidate selection or as a mechanistic tool to document muscular toxicity emerging during drug development.

SOT 2017 POSTER >>

Follow UsCDI TwitterCDI LinkedInCDI FacebookCDI Youtube

© 2017 Cellular Dynamics International, 525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688